Cargando…

Role of miR-520b in non-small cell lung cancer

The aim of the present study was to investigate the expression of microRNA (miR)-520b in non-small cell lung cancer (NSCLC) and its biological functions. Reverse transcription-quantitative polymerase chain reaction was used to detect the expression of miR-520b in 52 cases of NSCLC tissues, and its a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Linlin, Yu, Shuangquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200959/ https://www.ncbi.nlm.nih.gov/pubmed/30402147 http://dx.doi.org/10.3892/etm.2018.6732

Ejemplares similares

MiR‐520b promotes the progression of non‐small cell lung cancer through activating Hedgehog pathway
por: Liu, Xiaoming, et al.
Publicado: (2018)

MiR‐520b restrains cell growth by targeting HDAC4 in lung cancer
por: Jin, Ke, et al.
Publicado: (2018)

FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer
por: He, Wenfeng, et al.
Publicado: (2021)

MiR-520f acts as a biomarker for the diagnosis of lung cancer
por: Zhou, Yingyan, et al.
Publicado: (2019)

LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling
por: Liu, Xiaofeng, et al.
Publicado: (2022)

LDL Receptor Pathway Regulation by miR-224 and miR-520d
por: Salerno, Alessandro G., et al.
Publicado: (2020)

The Effect of miR-520b on Macrophage Polarization and T Cell Immunity by Targeting PTEN in Breast Cancer
por: Zhu, Qin, et al.
Publicado: (2021)

Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p
por: Liu, Yunpeng, et al.
Publicado: (2019)

miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway
por: Zhang, Hui, et al.
Publicado: (2019)

MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b
por: Tsukerman, Pinchas, et al.
Publicado: (2014)

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway
por: Huang, Yutang, et al.
Publicado: (2020)

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach
por: Gulhane, Pooja, et al.
Publicado: (2022)

Retraction: Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p
Publicado: (2022)

Expression of Concern: Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p
Publicado: (2022)

Hsa-miR-520d Converts Fibroblasts into CD105+ Populations
por: Ishihara, Yoshitaka, et al.
Publicado: (2014)

Hsa_circRNA_0017620 regulated cell progression of non‐small‐cell lung cancer via miR‐520a‐5p/KRT5 axis
por: Chen, Shan, et al.
Publicado: (2022)

GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer
por: Liu, Hao, et al.
Publicado: (2019)

LncRNA SNHG16 promotes non‐small cell lung cancer development through regulating EphA2 expression by sponging miR‐520a‐3p
por: Yu, Lin, et al.
Publicado: (2020)

MiR-520b inhibits proliferation, migration and invasion in gallbladder carcinoma by targeting RAB22A
por: Zhou, Jianpeng, et al.
Publicado: (2019)

Correction to: GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer
por: Liu, Hao, et al.
Publicado: (2022)

MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
por: Lu, Ya-Ching, et al.
Publicado: (2017)

Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP
por: Zhang, Weiying, et al.
Publicado: (2014)

High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis
por: Jin, Mingming, et al.
Publicado: (2020)

Diagnostic value of serum miR197 and miR145 in non-small cell lung cancer
por: Sui, Ankui, et al.
Publicado: (2019)

LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p
por: Wang, Yi, et al.
Publicado: (2022)

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer
por: Zhu, WangYu, et al.
Publicado: (2016)

miR-520d-5p can reduce the mutations in hepatoma cancer cells and iPSCs-derivatives
por: Miura, Norimasa, et al.
Publicado: (2019)

The lncRNA NORAD/miR-520a-3p Facilitates Malignancy in Non-Small Cell Lung Cancer via PI3k/Akt/mTOR Signaling Pathway
por: Wan, Yunyan, et al.
Publicado: (2020)

Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway
por: Xu, Xueliang, et al.
Publicado: (2020)

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015)

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
por: Li, Ming, et al.
Publicado: (2020)

miR-302c-3p and miR-520a-3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8
por: Ding, Hong-Mei, et al.
Publicado: (2021)

Downregulation of miR‐33b promotes non‐small cell lung cancer cell growth through reprogramming glucose metabolism miR‐33b regulates non‐small cell lung cancer cell growth
por: Zhai, Shengping, et al.
Publicado: (2018)

High expression of miR-155 and miR-21 in the recurrence or metastasis of non-small cell lung cancer
por: Xu, Shuang, et al.
Publicado: (2019)

Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer
por: Ding, Hao, et al.
Publicado: (2020)

Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients
por: Dezfuli, Neda K., et al.
Publicado: (2021)

Retracted: LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p
por: Healthcare Engineering, Journal of
Publicado: (2023)

MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma
por: Xu, Feng Feng, et al.
Publicado: (2017)

miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer
por: Geng, Wenwen, et al.
Publicado: (2020)

CyclinD1 Is a New Target Gene of Tumor Suppressor MiR-520e in Breast Cancer
por: Liang, Quan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lio918upqn2f6dv21pco0ggglv